Companies / TAO Synergies Inc.

TAO Synergies Inc.

Nasdaq: TAOXCIK 1571934NEW YORK, NY

Financials · FY2025

Revenue$299.1K
Net income$-28.74M
Total debt—
Cash$2.37M
Diluted EPS$-8.81
Shares outstanding7.5M

Ownership

7.5M shares outstanding · as of Mar 30, 2026
9.5%Institutions
Ownership
Institutions9.45%706,367
Public float90.55%6,765,564

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Tuchman Alan JChief Medical Officer · Director
——
Weinstein RobertChief Financial Officer
——

Institutional holders 27

View all →
HolderValue% of shares
Renaissance Technologies LLC$579.2K1.36%
Citadel Advisors LLC$521.5K1.90%
Geode Capital Management, LLC$504.7K1.19%
Quadrature Capital Ltd$239.0K0.87%
Vanguard Group Inc$236.7K0.86%
BlackRock, Inc.$171.2K0.61%
XTX Topco Ltd$167.9K0.61%
Summit Financial, LLC$115.8K0.42%
Jane Street Group, LLC$103.1K0.37%
State Street Corporation$94.0K0.34%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 18, 2026Weinstein Robert
Executive
GrantStock Option (Right to Buy)—+30K
30,000
0.40% of shares
low
Aug 6, 2025Tuchman Alan J
Executive
GrantEmployee Stock Option (right to buy)—+2K
2,000
0.03% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
TAOXCommon StockEquity87167T300BBG00YG4Q0S0